Table 2.
Study | Type | n | Initial AVN class | AVN etiology (# of hips) | Treatment protocol |
---|---|---|---|---|---|
Hernigou et al. [35] |
Case series |
534 |
Ficat 1-2 |
steroid (101), ethanol (150), sickle cell (166), not specified (117) |
Concentrated BMMNC |
Wang et al. [9] |
Case series |
50 |
ARCO 1-2 |
steroid (25), ethanol (19), idiopathic (6) |
Concentrated BMMNC |
Gangji et al. [2] |
nRCT |
24 |
ARCO 1-2 |
steroid (20), ethanol (2), idiopathic (2) |
Concentrated BMMNC |
Sen et al. [14] |
RCT |
51 |
ARCO 1-2 |
trauma (17), steroid (20), ethanol 8), idiopathic (2), pregnancy (2), Cushings (2) |
Concentrated BMMNC |
Zhao et al. [8] | RCT | 97 | ARCO 1C-2C | trauma (20), steroid (24), ethanol (19), Caisson (11), idiopathic (30) (some patients had more than one etiology) | Cultured BMMNC |
BMMNC = bone marrow mononuclear cells, n = number of hips, ARCO = Association Research Circulation Osseous classification, nRCT = non randomized control trial, RCT = randomized control trial.